Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis Abdulaziz S. AlzahraniMalcolm J. PriceVibhu Paudyal Review Open access 08 March 2021 Pages: 1259 - 1274
Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19 Suzy HuijghebaertLevi HosteGuido Vanham Review Open access 27 March 2021 Pages: 1275 - 1293
Correction to: Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19 Suzy HuijghebaertLevi HosteGuido Vanham Correction 24 April 2021 Pages: 1295 - 1295
Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19 Nils von Hentig Review Open access 04 March 2021 Pages: 1297 - 1307
Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review Laura NégrierAnthony Martin MenaBertrand Décaudin Review 25 March 2021 Pages: 1309 - 1321
Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low E. HeinonenM. BlennowK. Wide Clinical Trial Open access 22 March 2021 Pages: 1323 - 1331
Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves Heng ZhangMei LiLi Dong Clinical Trial 30 March 2021 Pages: 1333 - 1339
Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria Sikiru Olatunji UsmanIbrahim Adekunle OreagbaAlani Sulaimon Akanmu Pharmacokinetics and Disposition 23 March 2021 Pages: 1341 - 1348
S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults Lana TranMina NikanjamJoseph D. Ma Pharmacokinetics and Disposition 23 March 2021 Pages: 1349 - 1356
Population pharmacokinetic model of subcutaneous fentanyl in older acute care patients Aymen A. Al-QurainRichard UptonMichael D. Wiese Pharmacokinetics and Disposition 03 April 2021 Pages: 1357 - 1368
Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteers H. A. ElmekawyF. BelalF. Elbarbry Pharmacokinetics and Disposition 01 April 2021 Pages: 1369 - 1379
Medication incident recovery and prevention utilising an Australian community pharmacy incident reporting system: the QUMwatch study Khaled AdieRomano A. FoisTimothy F. Chen Pharmacoepidemiology and Prescription 01 March 2021 Pages: 1381 - 1395
Drug-drug interactions and inappropriate medicines impact on glycemic control and kidney function in older adults with diabetes-attending specialty care institution Labib AL-MusaweCarla TorreAna Paula Martins Pharmacoepidemiology and Prescription 20 March 2021 Pages: 1397 - 1407
Non-steroidal anti-inflammatory drug-associated acute kidney injury: does short-term NSAID use pose a risk in hospitalized patients? Nakyung JeonHaesuk ParkAlmut G. Winterstein Pharmacoepidemiology and Prescription 27 March 2021 Pages: 1409 - 1417
Anticholinergic load and delirium in end-of-life patients Luca PasinaBarbara RizziAngela Recchia Pharmacoepidemiology and Prescription 17 March 2021 Pages: 1419 - 1424
Quality, efficacy, safety—it is not enough! Silvio Garattini Point of View 09 March 2021 Pages: 1425 - 1426
Is there association between clinically relevant toxicities of pazopanib and sunitinib with the use of weak CYP3A4 and P-gp inhibitors? Setayesh SadeghiMona Kargar Letter to the Editor 16 March 2021 Pages: 1427 - 1428
Are adverse drug reactions to anti-diabetic drugs more common in patients whose treatment do not adhere to diabetes management clinical guidelines? Comments on a study report Zahra RezaieMaryam Taghizadeh-GhehiAarefeh Jafarzadeh Kohneloo Letter to the Editor 03 April 2021 Pages: 1429 - 1430
SGLT2 inhibitors and euglycemic diabetic ketoacidosis Zohaib YousafFateen AtaDabia Hamad S. H. Al Mohanadi Letter to the Editor 09 March 2021 Pages: 1431 - 1433
